Flywheel raises $22M, buys competitor
After closing a series C round led by 8VC, Flywheel used a portion of the funds to acquire St. Louis-based Radiologics. Both have platforms to help researchers process medical imaging data.
presented by
Wugen unveils $172M to take natural killer cell therapies to solid tumors
Wugen, a biotech developing “off-the-shelf” natural killer and CAR T cell therapies, has raised $172 million in Series B financing. The company’s lead program has already reached human testing and the new capital will be used to continue that research and advance other pipeline programs to the clinic.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Google, Ascension expand pilot of health record search tool
After Google struck a controversial partnership with Ascension to build a searchable health record, the companies are now launching an expanded clinical pilot of the tool. Now, about 250 clinicians will be able to use it.
Prominent electronic healthcare form solutions leader changing name to reflect broadening role in technology solutions sector
This month, FormFast will become Interlace Health
Makers of novel cell/gene therapy say off-the-shelf approach only way to solve pricing woes
In a recent interview, executives from two early-stage biopharma companies said that off-the-shelf approach is the only way to drive down the cost of novel cell and gene therapies like CAR-T.
Centene, WellCare get approval for $17.3B mega-merger
The two health insurance companies signaled that they had met all regulatory requirements for the merger, including review by the Department of Justice. Centene plans to close the acquisition on Thursday.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
PierianDx raises $27M in Series B to ‘democratize’ next-generation sequencing
The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs.
Centene bolsters its European presence with expanded stake in Spanish company
The deal increases Centene's ownership of the Spanish provider Ribera Salud from 50 percent to 90 percent.
How HarrisLogic is using data analytics to prevent suicides
St. Louis, Missouri-based HarrisLogic develops clinical services and population health management software for providers, schools and law enforcement intended to help users identify potential behavioral health issues within a population and divert them appropriate resources or sites of care.
Centene pledges up to $100M to fund personalized medicine initiative at Washington University
Innovations that emerge from the research will be commercialized through a joint venture between the school and Centene called the ARCH Personalized Medicine Initiative.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Ascension names first chief community impact officer
As of March 4, Tamarah Duperval-Brownlee holds the newly created role of senior vice president and chief community impact officer at Ascension.
OSF HealthCare leverages Epharmix for digital interventions
Through Epharmix, which offers condition-specific communication tools that allow care teams to remotely monitor patients, the health system can better connect with patients outside the hospital.
Express Scripts to expand network offerings to mail-order pharmacies in nod to changing consumer trends
The network expansion represents a willingness to engage with online pharmacy businesses in order to "evolve with industry trends," according to the company.
Cerner, Lumeris team to create solution to help providers with value-based care
As part of a 10-year relationship, the companies will develop the Maestro Advantage solution and Cerner will acquire a minority interest in Essence Group Holdings, Lumeris' parent company, for $266 million.
Two startups in Kaiser Permanente, Village Capital’s Health: US 2018 program earn $75K investment each
Two peer-selected startups — Advocatia and TCARE — have been named finalists of the program, which zeroes in on companies that address the needs of the aging population.